1. Document de presse | 2023.09.28

    Malaria: treatment of Plasmodium falciparum malaria patients under threat in the Horn of Africa

    Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa. Scientists from the Laboratory of Parasitology and Medical Mycology at the University of Strasbourg and Strasbourg University Hospital, in...

  2. News | 2022.11.14

    Monkeypox: a detailed profile of the disease

    Physicians and scientists from the Institut Pasteur, the Pasteur Network and ANRS | Emerging Infectious Diseases have conducted a review of the medical and scientific literature about monkeypox. The review, which paints a complete picture of the disease, was published in the New England Journal of Medicine on October 26, 2022. What are the signs of this disease? Where does it come from? How is it...

  3. Document de presse | 2026.02.16

    How age, sex and genetics shape our antibodies

    Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of scientists from the Institut Pasteur, the CNRS and the Collège de France have shown that these factors determine not only the quantity of antibodies produced but also the specific viral regions they target. This discovery could have major implications for the development of...

  4. News | 2026.03.12

    COVID-19: a new strategy under investigation to tackle all variants

    Scientists at the Institut Pasteur have developed an innovative strategy to combat SARS-CoV-2. Rather than targeting a virus in constant mutation, they propose blocking the gateway used by the virus to penetrate our cells. This is achieved by nasal administration of an antibody that protects against all known variants, paving the way for new therapies aimed at vulnerable individuals. This work,...

  5. Document de presse | 2013.05.05

    Chikungunya : discovery of a human-specific factor involved in the virus replication

    Scientists from the Institut Pasteur, Inserm and CNRS, have identified a human-specific factor involved in the replication of Chikungunya virus which accounts for the species specificity of this virus. Chikungunya virus is an emerging virus that in 2005 caused, for the first time, an outbreak in La Réunion island, a French overseas district where more than 30% of the population was infected, and...

  6. Document de presse | 2011.03.31

    AREVA Foundation and Institut Pasteur sign a new partnership agreement for Aids research

    AREVA Foundation continues to fight Aids alongside the Institut Pasteur in 2011. Two new Institute teams will benefit from the continuing partnership: • the team led by Professor Olivier Schwartz, who directs the Virus and Immunity Research Unit • the team of Dr. Michaela Müller of the Retroviral Infection Regulation Unit directed by Professor Barré-Sinoussi, Nobel Prize in Medicine....

  7. Document de presse | 2011.01.02

    Hepatitis C : in 2011, a predictive marker for response to therapy

    Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection. Their work, published in The Journal of Clinical Investigation, demonstrates that the plasma levels of the protein IP-10 predict, prior to treatment initiation, the efficacy of treatment with pegylated-interferon and ribavirin. Based on these results, the...

  8. Document de presse | 2013.08.01

    Dengue: identifying mosquito genetic factors that control virus transmission

    Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...

  9. Article | 2016.12.02

    Innovation and technology transfer

    Innovation development and technology transfer are promoted by the Institut Pasteur through its multidisciplinary and transversal approach to research. 

  10. News | 2016.12.15

    Two major types of rabies that evolved in different ways

    Scientists studying hundreds of genome sequences of the rabies virus at the Institut Pasteur have shown that two major viral types – bat rabies and dog rabies – evolved in different ways. These genetic data provide evolutionary models that may explain transmission between one species and another.Diseases transferred from vertebrate animals to humans represent a very real threat to human health....

Pages

Back to top